IDEBEST 45MG TABLET contains Idebenone 45mg, a synthetic analog of coenzyme Q10 with potent antioxidant properties. It is primarily indicated for the treatment of neurodegenerative disorders and mitochondrial dysfunction, where oxidative stress plays a critical role. Idebenone acts by facilitating electron transport in the mitochondrial respiratory chain, thereby enhancing cellular energy production and reducing free radical-induced damage. This mechanism supports neuronal survival and improves cognitive and motor functions in conditions such as Friedreich’s ataxia, Leber’s hereditary optic neuropathy, and other mitochondrial encephalopathies. IDEBEST is also investigated for its potential benefits in Alzheimer’s disease and age-related cognitive decline. The tablet is administered orally, with dosage and duration tailored according to the specific clinical condition and patient response. Commonly, IDEBEST is well tolerated, with adverse effects being rare but may include gastrointestinal disturbances or allergic reactions. It is contraindicated in patients with known hypersensitivity to Idebenone or any tablet excipients. Caution is advised when used concomitantly with other medications affecting mitochondrial function. IDEBEST 45MG TABLET should be used under medical supervision, ensuring appropriate monitoring to optimize therapeutic outcomes and minimize risks.